• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳头状尿路上皮癌患者膀胱单纯性尿路上皮增生中的频繁基因改变。

Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.

作者信息

Hartmann A, Moser K, Kriegmair M, Hofstetter A, Hofstaedter F, Knuechel R

机构信息

Institute of Pathology, University of Regensburg, Regensburg, Germany.

出版信息

Am J Pathol. 1999 Mar;154(3):721-7. doi: 10.1016/S0002-9440(10)65318-7.

DOI:10.1016/S0002-9440(10)65318-7
PMID:10079249
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1866404/
Abstract

In order to understand the origin of bladder cancer, very early urothelial lesions must be investigated in addition to more advanced tumors. Tissue from 31 biopsies of 12 patients with urothelial hyperplasias and simultaneous or consecutive superficial papillary tumors were used to microdissect urothelium from 15- microm sections of biopsies. The biopsies were obtained with the recently developed highly sensitive diagnostic method of 5-aminolevulinic acid-induced fluorescence endoscopy (AFE). Besides flat and papillary urothelial neoplasms, the method of photodynamic diagnostics also detects simple urothelial hyperplasias as fluorescent positive lesions. In addition, 12 fluorescence-positive biopsies showing histologically normal urothelium were investigated. Fluorescence in situ hybridization was done using a dual color staining technique of biotinylated centromeric probes of chromosomes 9 and 17 and digoxigenin-labeled gene-specific P1 probes for chromosomes 9q22 (FACC), 9p21(p16/CDKI2), and 17p13(p53). Ten of 14 hyperplasias (70%) showed deletions of chromosome 9. In 7 out of 8 patients with genetic alterations in the hyperplasias the genetic change was also present in the papillary tumor. Six out of 12 samples of microdissected normal urothelium also showed genetic alterations on chromosome 9. Microdissection of urothelial lesions, obtained during AFE, has led to the first unequivocal documentation of genetic changes in urothelial lesions diagnosed as normal in histopathology. Thus, this technical approach is important to provide insight into the earliest molecular alterations in bladder carcinogenesis.

摘要

为了了解膀胱癌的起源,除了更晚期的肿瘤外,还必须对非常早期的尿路上皮病变进行研究。来自12例尿路上皮增生患者的31份活检组织以及同时或相继出现的浅表乳头状肿瘤,用于从活检组织的15微米切片中显微切割尿路上皮。活检组织是通过最近开发的高灵敏度5-氨基乙酰丙酸诱导荧光内镜检查(AFE)诊断方法获取的。除了扁平状和乳头状尿路上皮肿瘤外,光动力诊断方法还能将单纯的尿路上皮增生检测为荧光阳性病变。此外,还对12份组织学上显示尿路上皮正常的荧光阳性活检组织进行了研究。荧光原位杂交采用双色染色技术,使用生物素化的9号和17号染色体着丝粒探针以及地高辛标记的9q22(FACC)、9p21(p16/CDKI2)和17p13(p53)染色体基因特异性P1探针。14例增生中有10例(70%)显示9号染色体缺失。在增生中发生基因改变的8例患者中,有7例乳头状肿瘤也存在基因改变。12份显微切割的正常尿路上皮样本中有6份也显示9号染色体存在基因改变。在AFE过程中获取的尿路上皮病变的显微切割,首次明确记录了组织病理学诊断为正常的尿路上皮病变中的基因变化。因此,这种技术方法对于深入了解膀胱癌发生过程中最早的分子改变具有重要意义。

相似文献

1
Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma.乳头状尿路上皮癌患者膀胱单纯性尿路上皮增生中的频繁基因改变。
Am J Pathol. 1999 Mar;154(3):721-7. doi: 10.1016/S0002-9440(10)65318-7.
2
Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses.通过比较基因组杂交(CGH)、杂合性缺失(LOH)和荧光原位杂交(FISH)分析检测到扁平尿路上皮增生及伴发的乳头状膀胱癌中频繁的基因改变。
J Pathol. 2003 Jan;199(1):50-7. doi: 10.1002/path.1259.
3
Fluorescence in situ hybridization detects frequent chromosome 9 deletions and aneuploidy in histologically normal urothelium of bladder cancer patients.荧光原位杂交检测到膀胱癌患者组织学正常的膀胱尿路上皮中频繁出现9号染色体缺失和非整倍体。
Oncol Rep. 2004 Apr;11(4):745-51.
4
Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.多色荧光原位杂交(UroVysion)在扁平尿路上皮病变鉴别诊断中的价值
J Clin Pathol. 2008 Mar;61(3):272-7. doi: 10.1136/jcp.2007.049684. Epub 2007 Aug 10.
5
Occurrence of chromosome 9 and p53 alterations in multifocal dysplasia and carcinoma in situ of human urinary bladder.人膀胱多灶发育异常及原位癌中9号染色体和p53改变的发生情况。
Cancer Res. 2002 Feb 1;62(3):809-18.
6
Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.膀胱癌患者组织学正常尿路上皮中9号染色体和8号染色体短臂的缺失
Eur Urol. 2005 Jan;47(1):58-63. doi: 10.1016/j.eururo.2004.07.012.
7
Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.通过组织病理学器官定位、杂合性缺失、荧光原位杂交和p53分析相结合,改进多灶性膀胱肿瘤的克隆性分析。
Hum Pathol. 2006 Feb;37(2):143-51. doi: 10.1016/j.humpath.2005.10.014. Epub 2005 Dec 15.
8
Chromosomal abnormalities in macroscopically normal urothelium in patients with bladder pT1 and pT2a urothelial carcinoma: a fluorescence in situ hybridization study and correlation with histologic features.膀胱pT1和pT2a期尿路上皮癌患者肉眼正常尿路上皮中的染色体异常:一项荧光原位杂交研究及其与组织学特征的相关性
Anal Quant Cytol Histol. 2005 Jun;27(3):143-51.
9
[Molecular changes in development and progression of urothelial carcinoma].[尿路上皮癌发生发展中的分子变化]
Verh Dtsch Ges Pathol. 2003;87:172-84.
10
Chromosome 9 deletions are more frequent than FGFR3 mutations in flat urothelial hyperplasias of the bladder.在膀胱扁平尿路上皮增生中,9号染色体缺失比FGFR3突变更常见。
Int J Cancer. 2006 Sep 1;119(5):1212-5. doi: 10.1002/ijc.21958.

引用本文的文献

1
Chromosomal instability by low-coverage whole-genome sequencing assay predicts prognosis in bladder cancer patients underwent radical cystectomy.通过低覆盖度全基因组测序分析检测到的染色体不稳定性可预测接受根治性膀胱切除术的膀胱癌患者的预后。
BMC Med Genomics. 2025 Jun 5;18(1):103. doi: 10.1186/s12920-025-02172-x.
2
5'-S-(3-Aminophenyl)-5'-thioadenosine, a Novel Chemoprotective Agent for Reducing Toxic Side Effects of Fluorouracil in Treatment of MTAP-Deficient Cancers.5'-S-(3-氨基苯基)-5'-硫代腺苷,一种新型化学保护剂,用于降低氟尿嘧啶治疗MTAP缺陷型癌症时的毒副作用。
Mol Cancer Ther. 2025 Jul 2;24(7):1030-1039. doi: 10.1158/1535-7163.MCT-24-0656.
3
Loss of MTAP expression is strongly linked to homozygous 9p21 deletion, unfavorable tumor phenotype, and noninflamed microenvironment in urothelial bladder cancer.在膀胱尿路上皮癌中,MTAP表达缺失与9p21纯合缺失、不良肿瘤表型及非炎症微环境密切相关。
J Pathol Clin Res. 2025 Jan;11(1):e70012. doi: 10.1002/2056-4538.70012.
4
Digital volumetric assessment of CIS and tumor mass compliments conventional histopathological assessment in muscle-invasive urothelial bladder cancer.对肌层浸润性膀胱尿路上皮癌中癌原位癌(CIS)和肿瘤肿块进行数字容积评估,可辅助传统组织病理学评估。
Virchows Arch. 2025 Apr;486(4):769-779. doi: 10.1007/s00428-024-03875-9. Epub 2024 Jul 19.
5
Photodynamic Diagnosis and Therapy in Non-Muscle-Invasive Bladder Cancer.非肌层浸润性膀胱癌的光动力诊断与治疗
Cancers (Basel). 2024 Jun 22;16(13):2299. doi: 10.3390/cancers16132299.
6
Biomarkers of Bladder Cancer: Cell-Free DNA, Epigenetic Modifications and Non-Coding RNAs.膀胱癌的生物标志物:游离 DNA、表观遗传修饰和非编码 RNA。
Int J Mol Sci. 2022 Oct 30;23(21):13206. doi: 10.3390/ijms232113206.
7
Advances in bladder cancer biology and therapy.膀胱癌生物学和治疗的进展。
Nat Rev Cancer. 2021 Feb;21(2):104-121. doi: 10.1038/s41568-020-00313-1. Epub 2020 Dec 2.
8
TERT C228T mutation in non-malignant bladder urothelium is associated with intravesical recurrence for patients with non-muscle invasive bladder cancer.TERT C228T 突变与非肌层浸润性膀胱癌患者的膀胱内复发相关。
Mol Oncol. 2020 Oct;14(10):2375-2383. doi: 10.1002/1878-0261.12746. Epub 2020 Jun 27.
9
Urothelial Proliferation of Unknown Malignant Potential Involving the Bladder: Histopathologic Features and Risk of Progression in De Novo Cases and Cases With Prior Neoplasia.不明恶性潜能的尿路上皮增殖累及膀胱:初发病例和有既往肿瘤病例的组织病理学特征及进展风险。
Arch Pathol Lab Med. 2020 Jul 1;144(7):853-862. doi: 10.5858/arpa.2019-0005-OA.
10
CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making.CDKN2A 作为肌层浸润性膀胱癌风险分层和治疗决策的转录组标志物。
Sci Rep. 2018 Sep 26;8(1):14383. doi: 10.1038/s41598-018-32569-x.

本文引用的文献

1
Multiple mutation analyses in single tumor cells with improved whole genome amplification.利用改进的全基因组扩增技术对单个肿瘤细胞进行多重突变分析。
Am J Pathol. 1999 Jan;154(1):83-95. doi: 10.1016/S0002-9440(10)65254-6.
2
Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33.位于9q32 - q33的候选膀胱癌抑癌区域内一个基因(DBCCR1)的结构及基于甲基化的沉默
Genomics. 1998 Mar 15;48(3):277-88. doi: 10.1006/geno.1997.5165.
3
Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization.通过比较基因组杂交检测到的pTa期和pT1期乳头状膀胱癌之间显著的基因差异。
Cancer Res. 1997 Jul 15;57(14):2860-4.
4
5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges.基于5-氨基酮戊酸的光动力疗法。临床研究与未来挑战。
Cancer. 1997 Jun 15;79(12):2282-308. doi: 10.1002/(sici)1097-0142(19970615)79:12<2282::aid-cncr2>3.0.co;2-o.
5
Intraepithelial lesions of the urinary bladder with a discussion of the histogenesis of urothelial neoplasia.膀胱上皮内病变并讨论尿路上皮肿瘤的组织发生学
Semin Diagn Pathol. 1997 May;14(2):84-97.
6
A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC.膀胱癌中位于9q32 - 33的一个新型候选肿瘤抑制基因座:候选区域在单个840 kb酵母人工染色体中的定位
Hum Mol Genet. 1997 Jun;6(6):913-9. doi: 10.1093/hmg/6.6.913.
7
Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia.人膀胱癌中17号染色体改变的组织学与基因图谱叠加分析
Oncogene. 1997 May 1;14(17):2059-70. doi: 10.1038/sj.onc.1201044.
8
Papillary urothelial hyperplasia. A precursor to papillary neoplasms.乳头样尿路上皮增生。乳头样肿瘤的一种前驱病变。
Am J Surg Pathol. 1996 Dec;20(12):1481-8. doi: 10.1097/00000478-199612000-00007.
9
Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.与膀胱癌中近端9号染色体p臂至q臂以及远端9号染色体q臂相关的两个肿瘤抑制基因座的证据及GAS1和PTC突变的初步筛查。
Cancer Res. 1996 Nov 1;56(21):5039-43.
10
Role of chromosome 9 in human bladder cancer.9号染色体在人类膀胱癌中的作用。
Cancer Res. 1993 Sep 1;53(17):4066-70.